UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services. In 2020, it was the second-largest healthcare company (behind CVS Health) by revenue with $257.1 billion, and the largest insurance company by net premiums. UnitedHealthcare revenues comprise 80% of the Group's overall revenue.
| Revenue (TTM) | $450.13B |
| Gross Profit (TTM) | $87.84B |
| EBITDA | $24.26B |
| Operating Margin | 7.13% |
| Return on Equity | 14.10% |
| Return on Assets | 4.38% |
| Revenue/Share (TTM) | $497.38 |
| Book Value | $115.36 |
| Price-to-Book | 3.88 |
| Price-to-Sales (TTM) | 0.86 |
| EV/Revenue | 0.947 |
| EV/EBITDA | 18.65 |
| Quarterly Earnings Growth (YoY) | 61.50% |
| Quarterly Revenue Growth (YoY) | 0.40% |
| Shares Outstanding | $908.14M |
| Float | $903.29M |
| % Insiders | 0.23% |
| % Institutions | 86.22% |
Volatility is currently expanding
UNH's improving cost control, lower medical costs and higher 2026 outlook are boosting confidence as its profitability recovery gains traction.
MMM, TRV and UNH posted strong Q2 results, with higher guidance, investment strength and growth drivers supporting their 2026 outlooks.
July has dealt Wall Street a turbulent hand. US stocks have drifted lower this month, hampered by persistent geopolitical risks, rising crude oil prices, and mounting anxiety over rising AI capex.
UNH's post-earnings pullback follows a 52-week high, as stronger guidance offsets Medicaid pressures and spotlights healthcare ETFs with sizable exposure.
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
UnitedHealth Group (UNH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
UnitedHealth's raised premiums have worked as intended in driving the healthier membership base, as observed in the lower Medical Care Ratio and richer margins. Optum's integrated care management post-hospitalization and the accelerated adoption of their transparent pharmacy pricing underpin future recovery trends. The shareholder return prospects across share repurchases/dividends may remain resilient, aided by the potential upside to my LTPT of $521.70.
UnitedHealth (UNH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on UNH and any ticker you trade — then tracks every position and per-strategy win rate.
